The ILAP and the Aligned Pathway: What's the difference?

1st July 2026

Summary: This MHRA blog outlines the distinct purposes of the Innovative Licensing and Access Pathway (ILAP) and the Aligned Pathway. While ILAP is designed to support the development of innovative medicines that address unmet patient needs through coordinated regulatory and stakeholder engagement, the Aligned Pathway offers a streamlined regulatory route that aligns UK assessments with trusted international regulators. The article explains the eligibility criteria, benefits and intended use of each pathway, helping developers understand which approach best suits their product and development strategy.

Link: https://medregs.blog.gov.uk/2026/06/24/the-ilap-and-the-aligned-pathway-whats-the-difference/

Back to Recent News